Huda Zoghbi is a Howard Hughes Medical Institute investigator and professor of molecular and human genetics at Baylor College of Medicine in Houston, Texas. She is also director of the Jan and Dan Duncan Neurological Research Institute. Zoghbi explores the biology of genetic disorders such as Rett syndrome, and the genes essential for normal neurodevelopment.
Huda Zoghbi
Professor
Baylor College of Medicine
From this contributor
Remembering Steve Warren (1953-2021): A giant in the field of genetics
Steve Warren co-discovered the genetic mechanism that underpins fragile X syndrome and was a generous, inspiring mentor to many.
Remembering Steve Warren (1953-2021): A giant in the field of genetics
By
Joseph Cubells, Evan Eichler, James Sutcliffe, Huda Zoghbi
6 September 2021 | 11 min read
Questions for Huda Zoghbi: Studying Rett in the rodent brain
Removing the Rett syndrome gene, MeCP2, from distinct cells and brain regions reveals hidden features of the condition.
Questions for Huda Zoghbi: Studying Rett in the rodent brain
By
Jessica Wright
14 March 2017 | 6 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read